Tyrosine Kinase Inhibitors and Vascular Toxicity: Impetus for a Classification System?
出版年份 2016 全文链接
标题
Tyrosine Kinase Inhibitors and Vascular Toxicity: Impetus for a Classification System?
作者
关键词
Angina, Cancer, Cardiomyopathy, Chemotherapy, Endothelial dysfunction, Myocardial infarction, Stroke, Thrombosis, Vasospasm
出版物
Current Oncology Reports
Volume 18, Issue 6, Pages -
出版商
Springer Nature
发表日期
2016-04-21
DOI
10.1007/s11912-016-0514-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cardiovascular risk assessments in chronic myeloid leukemia allow identification of patients at high risk of cardiovascular events during treatment with nilotinib
- (2015) Massimo Breccia et al. AMERICAN JOURNAL OF HEMATOLOGY
- Clinical features of pulmonary arterial hypertension in patients receiving dasatinib
- (2015) Neil P. Shah et al. AMERICAN JOURNAL OF HEMATOLOGY
- Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors
- (2015) J S L Kloth et al. BRITISH JOURNAL OF CANCER
- Tyrosine Kinase Inhibitor–Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia
- (2015) Javid J. Moslehi et al. JOURNAL OF CLINICAL ONCOLOGY
- Complicated and Advanced Atherosclerosis in a Young Woman With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Success and Challenges of BCR/ABL1–Targeted Cancer Therapy
- (2015) Joerg Herrmann et al. MAYO CLINIC PROCEEDINGS
- The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear
- (2015) Cassandra P. Loren et al. THROMBOSIS RESEARCH
- FDA-approved small-molecule kinase inhibitors
- (2015) Peng Wu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?
- (2015) Tulay Kus et al. OncoTargets and Therapy
- Cardiovascular Toxicity of Multi-Tyrosine Kinase Inhibitors in Advanced Solid Tumors: A Population-Based Observational Study
- (2015) Amirrtha Srikanthan et al. PLoS One
- Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: An up-to-date meta-analysis
- (2014) Wei-Xiang Qi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Role of epidermal growth factor receptor in vascular structure and function
- (2014) Barbara Schreier et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Cardiovascular events among 1090 cancer patients treated with sunitinib, interferon, or placebo: A comprehensive adjudicated database analysis demonstrating clinically meaningful reversibility of cardiac events
- (2014) Michael S. Ewer et al. EUROPEAN JOURNAL OF CANCER
- Safety profile of combined therapy inhibiting EFGR and VEGF pathways in patients with advanced non-small-cell lung cancer: A meta-analysis of 15 phase II/III randomized trials
- (2014) Wang Ma et al. INTERNATIONAL JOURNAL OF CANCER
- Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
- (2014) Juan Carlos Plana et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
- (2014) Anne Polk et al. BMC Pharmacology & Toxicology
- Toxic cardiomyopathy leading to fatal acute cardiac failure related to vandetanib: a case report with histopathological analysis
- (2013) Rafael Selbach Scheffel et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Systemic VEGF inhibition accelerates experimental atherosclerosis and disrupts endothelial homeostasis – implications for cardiovascular safety
- (2013) Stephan Winnik et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib
- (2013) T D Kim et al. LEUKEMIA
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias
- (2013) J.E. Cortes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abl Family Kinases Regulate Endothelial Barrier Function In Vitro and in Mice
- (2013) Elizabeth M. Chislock et al. PLoS One
- Coronary Microvascular Pericytes Are the Cellular Target of Sunitinib Malate-Induced Cardiotoxicity
- (2013) V. Chintalgattu et al. Science Translational Medicine
- Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib
- (2012) Maria Abbondanza Pantaleo et al. BMC CANCER
- Effective Treatment of Edema and Endothelial Barrier Dysfunction With Imatinib
- (2012) Jurjan Aman et al. CIRCULATION
- Pulmonary Arterial Hypertension in Patients Treated by Dasatinib
- (2012) David Montani et al. CIRCULATION
- Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias
- (2012) Jorge E. Cortes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating endothelial progenitor cells do not contribute to regeneration of endothelium after murine arterial injury
- (2011) Mette K. Hagensen et al. CARDIOVASCULAR RESEARCH
- Sorafenib-associated multivessel coronary artery vasospasm
- (2011) T. Naib et al. HERZ
- The Vascular Endothelial Growth Factor Receptor Inhibitor Sunitinib Causes a Preeclampsia-Like Syndrome With Activation of the Endothelin System
- (2011) Mariëtte H.W. Kappers et al. HYPERTENSION
- Sunitinib-Induced Systemic Vasoconstriction in Swine Is Endothelin Mediated and Does Not Involve Nitric Oxide or Oxidative Stress
- (2011) Mariëtte H.W. Kappers et al. HYPERTENSION
- Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis of randomized controlled trials
- (2010) Vishal Ranpura et al. ACTA ONCOLOGICA
- Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes
- (2010) F. A. B. Schutz et al. ANNALS OF ONCOLOGY
- Circulating Endothelial Progenitor Cells Do Not Contribute to Plaque Endothelium in Murine Atherosclerosis
- (2010) Mette K. Hagensen et al. CIRCULATION
- Hypertension Induced by the Tyrosine Kinase Inhibitor Sunitinib Is Associated With Increased Circulating Endothelin-1 Levels
- (2010) Mariëtte H.W. Kappers et al. HYPERTENSION
- VEGF pathway inhibition by anticancer agent sunitinib and susceptibility to atherosclerosis plaque disruption
- (2010) Stanislas Ropert et al. INVESTIGATIONAL NEW DRUGS
- Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials
- (2010) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- A case of variant angina in a patient under chronic treatment with sorafenib
- (2010) Italo Porto et al. Nature Reviews Clinical Oncology
- Sorafenib-induced acute myocardial infarction due to coronary artery spasm
- (2009) Yuichiro Arima et al. Journal of Cardiology
- Atherosclerotic plaque development and instability: A dual role for VEGF
- (2008) Pieter W. Holm et al. ANNALS OF MEDICINE
- Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis
- (2008) Hugues de Lavallade et al. BRITISH JOURNAL OF HAEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation